Oi, you're doing this on purpose.
They didn't mention about doing CF phase II again anywhere. For Tomix and the board, I'm below adding the one extra sentence from the translation I posted yesterday.
"The other products, which do not compete with us because CF patients receive drugs on drugs today, showed a result of 2.5 units, so 3.4 is excellent This number is a significant improvement for patients, no matter where they are in their performance index, and we are currently in the process of consulting with experts on the next stage of the trial. Before that, you need to file a protocol and discuss with the FDA about measures to look at Lev 3, which could be much larger and count about 500 patients. "
"Lev 3" is the google translation of the Hebrew, "??? 3 " which also means "stage 3" or "phase 3". So they will be looking at the next stage which is to do phase III with about 500 patients.
Phase II was definitively positive, "significant improvement for patients, no matter where they are in their performance index" and as quoted in my yesterday's post from this same article, "better than the competition", and they are discussing with experts on CF Phase III with a current estimated 500 patients.
Tomix, seriously, stop creating things that aren't there. Again your statement isn't even a point of view on a fact. There is nothing saying CF Phase II was a failure, everything evidencing that CF Phase II was Positive and nothing saying they are doing CF Phase II again, but saying that they are progressing to CF Phase III.
